340 related articles for article (PubMed ID: 30571694)
1. Lrrk promotes tau neurotoxicity through dysregulation of actin and mitochondrial dynamics.
Bardai FH; Ordonez DG; Bailey RM; Hamm M; Lewis J; Feany MB
PLoS Biol; 2018 Dec; 16(12):e2006265. PubMed ID: 30571694
[TBL] [Abstract][Full Text] [Related]
2. Oligomerization of Lrrk controls actin severing and α-synuclein neurotoxicity in vivo.
Sarkar S; Bardai F; Olsen AL; Lohr KM; Zhang YY; Feany MB
Mol Neurodegener; 2021 May; 16(1):33. PubMed ID: 34030727
[TBL] [Abstract][Full Text] [Related]
3. G2019S LRRK2 enhances the neuronal transmission of tau in the mouse brain.
Nguyen APT; Daniel G; Valdés P; Islam MS; Schneider BL; Moore DJ
Hum Mol Genet; 2018 Jan; 27(1):120-134. PubMed ID: 29088368
[TBL] [Abstract][Full Text] [Related]
4. Novel ethyl methanesulfonate (EMS)-induced null alleles of the Drosophila homolog of LRRK2 reveal a crucial role in endolysosomal functions and autophagy in vivo.
Dodson MW; Leung LK; Lone M; Lizzio MA; Guo M
Dis Model Mech; 2014 Dec; 7(12):1351-63. PubMed ID: 25288684
[TBL] [Abstract][Full Text] [Related]
5. LRRK2 phosphorylates novel tau epitopes and promotes tauopathy.
Bailey RM; Covy JP; Melrose HL; Rousseau L; Watkinson R; Knight J; Miles S; Farrer MJ; Dickson DW; Giasson BI; Lewis J
Acta Neuropathol; 2013 Dec; 126(6):809-27. PubMed ID: 24113872
[TBL] [Abstract][Full Text] [Related]
6. Cognitive enhancement, TAU phosphorylation reduction, and neuronal protection by the treatment of an LRRK2 inhibitor in a tauopathy mouse model.
Castro-Sánchez S; Zaldivar-Diez J; Luengo E; López MG; Gil C; Martínez A; Lastres-Becker I
Neurobiol Aging; 2020 Dec; 96():148-154. PubMed ID: 33007689
[TBL] [Abstract][Full Text] [Related]
7. Lack of exacerbation of neurodegeneration in a double transgenic mouse model of mutant LRRK2 and tau.
Mikhail F; Calingasan N; Parolari L; Subramanian A; Yang L; Flint Beal M
Hum Mol Genet; 2015 Jun; 24(12):3545-56. PubMed ID: 25804954
[TBL] [Abstract][Full Text] [Related]
8. Rac1 protein rescues neurite retraction caused by G2019S leucine-rich repeat kinase 2 (LRRK2).
Chan D; Citro A; Cordy JM; Shen GC; Wolozin B
J Biol Chem; 2011 May; 286(18):16140-9. PubMed ID: 21454543
[TBL] [Abstract][Full Text] [Related]
9. Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: relevance to Parkinson disease.
Di Domenico F; Sultana R; Ferree A; Smith K; Barone E; Perluigi M; Coccia R; Pierce W; Cai J; Mancuso C; Squillace R; Wiengele M; Dalle-Donne I; Wolozin B; Butterfield DA
Antioxid Redox Signal; 2012 Dec; 17(11):1490-506. PubMed ID: 22315971
[TBL] [Abstract][Full Text] [Related]
10. LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1.
Wang X; Yan MH; Fujioka H; Liu J; Wilson-Delfosse A; Chen SG; Perry G; Casadesus G; Zhu X
Hum Mol Genet; 2012 May; 21(9):1931-44. PubMed ID: 22228096
[TBL] [Abstract][Full Text] [Related]
11. Loss of LRRK2/PARK8 induces degeneration of dopaminergic neurons in Drosophila.
Lee SB; Kim W; Lee S; Chung J
Biochem Biophys Res Commun; 2007 Jun; 358(2):534-9. PubMed ID: 17498648
[TBL] [Abstract][Full Text] [Related]
12. LRRK2 I2020T mutation is associated with tau pathology.
Ujiie S; Hatano T; Kubo S; Imai S; Sato S; Uchihara T; Yagishita S; Hasegawa K; Kowa H; Sakai F; Hattori N
Parkinsonism Relat Disord; 2012 Aug; 18(7):819-23. PubMed ID: 22525366
[TBL] [Abstract][Full Text] [Related]
13. The Drosophila hep pathway mediates Lrrk2-induced neurodegeneration.
Yang D; Thomas JM; Li T; Lee Y; Liu Z; Smith WW
Biochem Cell Biol; 2018 Aug; 96(4):441-449. PubMed ID: 29268033
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of excessive mitochondrial fission reduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutation.
Su YC; Qi X
Hum Mol Genet; 2013 Nov; 22(22):4545-61. PubMed ID: 23813973
[TBL] [Abstract][Full Text] [Related]
15. The G2019S LRRK2 mutation increases myeloid cell chemotactic responses and enhances LRRK2 binding to actin-regulatory proteins.
Moehle MS; Daher JP; Hull TD; Boddu R; Abdelmotilib HA; Mobley J; Kannarkat GT; Tansey MG; West AB
Hum Mol Genet; 2015 Aug; 24(15):4250-67. PubMed ID: 25926623
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of amyloid precursor protein by mutant LRRK2 promotes AICD activity and neurotoxicity in Parkinson's disease.
Chen ZC; Zhang W; Chua LL; Chai C; Li R; Lin L; Cao Z; Angeles DC; Stanton LW; Peng JH; Zhou ZD; Lim KL; Zeng L; Tan EK
Sci Signal; 2017 Jul; 10(488):. PubMed ID: 28720718
[TBL] [Abstract][Full Text] [Related]
17. Cell-autonomous role of leucine-rich repeat kinase in the protection of dopaminergic neuron survival.
Kang J; Huang G; Ma L; Tong Y; Shahapal A; Chen P; Shen J
Elife; 2024 Jun; 12():. PubMed ID: 38856715
[TBL] [Abstract][Full Text] [Related]
18. Physiologically relevant factors influence tau phosphorylation by leucine-rich repeat kinase 2.
Hamm M; Bailey R; Shaw G; Yen SH; Lewis J; Giasson BI
J Neurosci Res; 2015 Oct; 93(10):1567-80. PubMed ID: 26123245
[TBL] [Abstract][Full Text] [Related]
19. LRRK2 guides the actin cytoskeleton at growth cones together with ARHGEF7 and Tropomyosin 4.
Häbig K; Gellhaar S; Heim B; Djuric V; Giesert F; Wurst W; Walter C; Hentrich T; Riess O; Bonin M
Biochim Biophys Acta; 2013 Dec; 1832(12):2352-67. PubMed ID: 24075941
[TBL] [Abstract][Full Text] [Related]
20. LRRK2 Facilitates tau Phosphorylation through Strong Interaction with tau and cdk5.
Shanley MR; Hawley D; Leung S; Zaidi NF; Dave R; Schlosser KA; Bandopadhyay R; Gerber SA; Liu M
Biochemistry; 2015 Aug; 54(33):5198-208. PubMed ID: 26268594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
